Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on April 9, 2025

Stella-Jones’ First Quarter Results Conference Call and Annual Meeting of Shareholders

Stella-Jones’ First Quarter Results Conference Call and Annual Meeting of Shareholders

MONTRÉAL, April 09, 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ), (“Stella-Jones” or “the Company”) will hold a conference call to discuss its first quarter results: THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE …

Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer

Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer

WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the …

Téléconférence du premier trimestre et assemblée annuelle des actionnaires de Stella-Jones

Téléconférence du premier trimestre et assemblée annuelle des actionnaires de Stella-Jones

MONTRÉAL, 09 avr. 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX : SJ) (« Stella-Jones » ou « la Société» tiendra une téléconférence pour discuter des résultats du premier trimestre. LE COMMUNIQUÉ SERA DIFFUSÉ PAR GLOBE NEWSWIRE LE JOUR MÊME DE LA …

KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

LEXINGTON, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing treatments for solid tumors, today announced the first patient dosed in the Phase 1/2 clinical study of KSQ-004EX, a novel …

Talisker Initiates Lateral Development on Alhambra Vein at the Bralorne Gold Project

Talisker Initiates Lateral Development on Alhambra Vein at the Bralorne Gold Project

TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce it has begun lateral development on the Alhambra Vein on the 1105 level at the Bralorne Gold Project. To date, …

Horizon Aircraft to Participate in Upcoming Investor Conferences in April 2025

Horizon Aircraft to Participate in Upcoming Investor Conferences in April 2025

TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- New Horizon Aircraft (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), an advanced aerospace engineering company and developer of the world’s first eVTOL (electric Vertical …

APA Corporation Provides First-Quarter 2025 Supplemental Information and Schedules Results Conference Call for May 8 at 10 a.m. Central Time

APA Corporation Provides First-Quarter 2025 Supplemental Information and Schedules Results Conference Call for May 8 at 10 a.m. Central Time

HOUSTON, April 09, 2025 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain first-quarter 2025 financial and operational results. This information is intended only to provide additional information …

Osisko Announces Preliminary Q1 2025 GEO Deliveries and Strong Quarterly Cash Margin

Osisko Announces Preliminary Q1 2025 GEO Deliveries and Strong Quarterly Cash Margin

MONTREAL, April 09, 2025 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX …

Osisko annonce les livraisons préliminaires d’onces d’équivalent d’or pour le premier trimestre de 2025 et une forte marge monétaire trimestrielle

Osisko annonce les livraisons préliminaires d’onces d’équivalent d’or pour le premier trimestre de 2025 et une forte marge monétaire trimestrielle

MONTRÉAL, 09 avr. 2025 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses produits et sa marge monétaire préliminaires pour le premier …

A.I.S. Resources Announces Option Grant

A.I.S. Resources Announces Option Grant

VANCOUVER, British Columbia, April 09, 2025 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces the grant of a total of 500,000 incentive stock options to a director in accordance with the Company’s …

Endeavour Silver Produces 1,205,793 Oz Silver and 8,338 Oz Gold (1.9 Million Silver Equivalent Oz) in Q1 2025

Endeavour Silver Produces 1,205,793 Oz Silver and 8,338 Oz Gold (1.9 Million Silver Equivalent Oz) in Q1 2025

VANCOUVER, British Columbia, April 09, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports first quarter 2025 production of 1,205,793 silver ounces (oz) and 8,338 gold oz, for silver equivalent(1) (“ …

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2025 financial results on Friday, May 9, 2025, prior to the market open. …

Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025

Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025

ORION CORPORATION PRESS RELEASE 9 APRIL 2025 at 13.30 EEST                    Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025 Orion will publish Interim Report for January–March 2025 on Wednesday, 23 April 2025 at …

Orion julkaisee osavuosikatsauksen 1–3/2025 ja järjestää verkkolähetyksen 23.4.2025

Orion julkaisee osavuosikatsauksen 1–3/2025 ja järjestää verkkolähetyksen 23.4.2025

ORION OYJ                 LEHDISTÖTIEDOTE 9.4.2025 KLO 13.30          Orion julkaisee osavuosikatsauksen 1–3/2025 ja järjestää verkkolähetyksen 23.4.2025 Orion julkaisee osavuosikatsauksen 1–3/2025 keskiviikkona 23.4.2025 noin klo 12.00. Tiedote ja siihen …

DIAGNOS Provides Update on its Health Canada Medical Device Licence Application

DIAGNOS Provides Update on its Health Canada Medical Device Licence Application

BROSSARD, Quebec, April 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial …

DIAGNOS fait le point sur sa demande d'homologation d'un instrument médical auprès de Santé Canada

DIAGNOS fait le point sur sa demande d'homologation d'un instrument médical auprès de Santé Canada

BROSSARD, Québec, 09 avr. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un pionnier de la détection précoce de certains problèmes de santé ophtalmique à l'aide d'une …

Bilibili Publishes 2024 Environmental, Social and Governance Report

Bilibili Publishes 2024 Environmental, Social and Governance Report

SHANGHAI, April 09, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has published its 2024 …

Radware Schedules Conference Call for Its First Quarter 2025 Earnings

Radware Schedules Conference Call for Its First Quarter 2025 Earnings

TEL AVIV, Israel, April 09, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, will announce its first quarter results on Wednesday, May 7, 2025. Conference Call …

Coave Therapeutics to Attend Upcoming Conferences

Coave Therapeutics to Attend Upcoming Conferences

Paris, France, April 9, 2025 – Coave Therapeutics (‘Coave’), a company pioneering the future of genetic medicines, announces that members of its leadership team will be attending the following industry conferences: Cell …

TransUnion Study Finds More than Half (56%) of Canadians Said They Were Targeted by Fraud in Second Half of 2024

TransUnion Study Finds More than Half (56%) of Canadians Said They Were Targeted by Fraud in Second Half of 2024

Almost One in Five (17%) Canadians Reported Losing Money Due to Fraud in Last Year with Median Loss of $2,013 Gaming, Government and Communities were Most Targeted Sectors by Digital Fraudsters in Canada Key Study Findings: 39% of Canadians surveyed said …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service